Atlas Trials

A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

Clinical trial NCT06506591 · COMPLETED

Trial details

NCT number
NCT06506591
Sponsor
Zhejiang Wenda Pharma Technology LTD.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2023-10-26
Primary completion
2024-08-15
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.